Chen Jing 4
4 · Biostage, Inc. · Filed Jun 29, 2020
Insider Transaction Report
Form 4
Biostage, Inc.BSTG
Chen Jing
Director
Transactions
- Award
Stock Option (right to buy)
2020-06-25+9,579→ 21,517 totalExercise: $2.52Exp: 2030-06-25→ Common Stock, par value $0.01 per share (9,579 underlying) - Award
Stock Option (right to buy)
2020-06-25+11,938→ 11,938 totalExercise: $2.52Exp: 2030-06-25→ Common Stock, par value $0.01 per share (11,938 underlying)
Footnotes (2)
- [F1]This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 25, 2020, December 25, 2020, March 25, 2021, and June 25, 2021.
- [F2]This Stock Option was granted in lieu of 2020 cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2020, September 30, 2020 and December 31, 2020.